share_log

Iovance Biotherapeutics Affirms FY2024 Product Sales Guidance From $160.00M-165.00M to $160.00M-165.00M

Benzinga ·  05:43

Iovance Biotherapeutics (NASDAQ:IOVA) affirms FY2024 Product sales outlook from $160.00 million-165.00 million to $160.00 million-165.00 million.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment